Clinical trials
Diabetes Mellitus clinical trials
Below are recruiting diabetes mellitus clinical trials, each written for real people, not researchers. We’re tracking 887 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04993482Recruiting
Tracks daily movement habits in adults with type 2 diabetes
This study looks at your usual 24-hour movement pattern (like being active, sitting, and sleeping). It may help researchers better understand daily behavior patterns in people with type 2 diabetes.
GhentAges 18–100 - NCT06290544Recruiting
Heart Risk Study for Italian Adults with Type 1 Diabetes
This study looks at heart health in adults with type 1 diabetes. By joining, you'll help doctors better understand how to prevent heart problems in people like you.
MilanAges 18 years+ - NCT06487130Recruiting
Australia menopause registry study
This study is building a registry to better understand and support Australians going through perimenopause or menopause. By joining, you help researchers learn about the experiences and needs of people in this stage of life.
AdelaideAges 18 years+ - NCT06937203RecruitingPhase 1/Phase 2
A new obesity drug study for people with or without type 2 diabetes
This early-stage study tests an investigational drug called ARO-ALK7 to see if it helps adults with obesity lose weight. It includes people who have type 2 diabetes as well as those who do not, and requires that you have tried to lose weight with lifestyle changes in the past.
Morayfield, QLCAges 18–65 - NCT06642623RecruitingPhase 4
Study on heart and kidney health in type 2 diabetes
This trial tests enavogliflozin (a newer SGLT2 inhibitor) compared to older drugs (dapagliflozin or empagliflozin) to see how well it protects the heart and kidneys in people with type 2 diabetes.
SeoulAges 19 years+ - NCT06648174Recruiting
Managing heart health risk after gestational diabetes
This study tests a program to help women who had gestational diabetes reduce their future risk of heart disease and diabetes. It checks if monitoring and support can improve health after pregnancy.
HsinchuAges 18 years+ - NCT07685015Recruiting
Myo-Inositol for blood sugar control in gestational diabetes
This trial tests if a natural supplement called myo-inositol can help manage blood sugar and reduce stress on your body during pregnancy while you have gestational diabetes.
Vienna, State of ViennaAges 18–45 - NCT06842108Recruiting
Blood flow and heart-lung fitness in type 2 diabetes
This study looks at how blood flow changes (hemodynamics) affect your heart and lung fitness (cardiopulmonary fitness) in people with type 2 diabetes. It may help doctors understand how diabetes affects the heart and lungs.
Karachi, SindhAges 30–50 - NCT06955611Recruiting
Is home monitoring safe for early diabetic eye problems?
This trial tests whether monitoring certain diabetic eye changes in the community is as safe as hospital checks. It's for people with early signs of diabetic eye disease that haven't yet reached a more advanced stage.
HaverfordwestAges 18 years+ - NCT07159282RecruitingPhase 4
Placental graft for diabetic foot ulcers that didn't close
This trial tests a placental-based graft for diabetic foot ulcers that did not heal after 12 weeks of standard care in a previous study (CAMPX). It aims to help people whose wounds are still open despite good wound care.
Hollywood, FloridaAges 18 years+ - NCT07231341Recruiting
Insulin resistance study in gestational diabetes
This study looks at insulin resistance in pregnant women with gestational diabetes. It aims to understand how the body uses insulin during pregnancy to help improve care for women with this condition.
AarhusAges 18 years+ - NCT07619157RecruitingPhase 1
ONO-3310 Study for Kidney Disease and Type 2 Diabetes
This early-stage trial tests a new drug called ONO-3310 in two groups: healthy adults and people with kidney disease caused by type 2 diabetes. The study aims to understand how the drug works and whether it might help protect kidney function in people with diabetes.
Fukuoka, FukuokaAges 18–64 - NCT07503028Enrolling by invitationEarly Phase 1
Stem cell therapy for severe low blood sugar in diabetes
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
Hefei, AnhuiAges 18–70 - NCT07073768Enrolling by invitationPhase 3
Comparing two diabetes pills for type 2 diabetes
This study compares two medications, trelagliptin and sitagliptin, to see which works better for people with type 2 diabetes. It might be an option if you are already taking metformin but your blood sugar levels are still not under control.
Peshawar, Khyber PakhtunkhwaAges Any age - NCT06856720Enrolling by invitation
Muscle stimulation, exercise, and blood sugar control in older adults with type 2 diabetes
This study tests if combining electrical muscle stimulation with exercise can help older adults with type 2 diabetes living in nursing homes better manage their blood sugar. Participants will receive supervised sessions over several weeks.
Viseu, Viseu DistrictAges 60 years+ - NCT07284511RecruitingPhase 2/Phase 3
Tirzepatide for automatic blood sugar control in type 1 diabetes
This trial tests if adding tirzepatide (a once-weekly injection) to an automated insulin pump system (Control-IQ) helps adults with type 1 diabetes better manage their blood sugar. It requires using the Tandem Control-IQ pump and counting carbohydrates.
Montreal, QuebecAges 18 years+ - NCT07391995Recruiting
New test for bacteria in diabetic foot infections
This trial tests a new portable device called MinION that can quickly identify bacteria in foot wounds of people with diabetic foot bone infections. It aims to help doctors choose the right antibiotic faster.
Nîmes, GardAges Any age - NCT07340320RecruitingPhase 2
CX11 tablets for type 2 diabetes
This trial tests an experimental drug called CX11 to see if it helps control blood sugar in people with type 2 diabetes who are already taking metformin. It may be an option for you if your blood sugar is not well controlled and you meet the health requirements.
Birmingham, AlabamaAges 18–75 - NCT07774078Recruiting
Remote monitoring to improve blood sugar control in diabetes
This trial tests whether using remote monitoring can help people with diabetes better control their blood sugar. Participants use a device or app to share blood sugar readings with their care team, which may lead to more tailored treatment.
MonastirAges 18 years+ - NCT07474376Recruiting
Audio diary app for diabetes with other health conditions
This trial tests if using an audio diary app can help people with diabetes and at least one other health condition, like obesity or heart failure, manage their health better. You can join if you have a smartphone and can use the app and online surveys.
Atlanta, GeorgiaAges 65 years+ - NCT07527650RecruitingPhase 2
Testing HM15275 for Type 2 Diabetes Management
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
Mesa, ArizonaAges 18–75 - NCT07757308Recruiting
Brain and heart connection in type 2 diabetes
This study looks at how type 2 diabetes affects the link between your brain and heart. Participants will undergo tests of memory, thinking, and heart function to see how these are related in diabetes.
TunceliAges 40–75 - NCT07662109RecruitingPhase 3
Testing a new combo pill for type 2 diabetes
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Huntsville, AlabamaAges 18 years+ - NCT07662044RecruitingPhase 3
Studying elecoglipron for type 2 diabetes
This trial tests a new medicine called elecoglipron, taken alone or with another diabetes drug (dapagliflozin), to see if it helps control blood sugar better than a placebo. It may be an option if your current treatment isn't working well enough.
Birmingham, AlabamaAges 18 years+
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus?
- Yes. Clin2 currently lists 887 recruiting diabetes mellitus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.